Literature DB >> 12106483

Characterization of a Voltage-dependent Calcium Current in the Human Neuroblastoma Cell Line SH-SY5Y During Differentiation.

M. Toselli1, S. Masetto, P. Rossi, V. Taglietti.   

Abstract

In the presence of retinoic acid, cultured human neuroblastoma SH-SY5Y cells grow processes indicative of neuronal differentiation. A voltage-gated Ca current is already present in undifferentiated cells. A gradual increase of the Ca current density occurs during cell differentiation. According to kinetic and pharmacological properties, Ca currents in differentiated cells are indistinguishable from those elicitable in undifferentiated cells and resemble features of the high-voltage activated currents present in mammalian neuronal cells. omega-conotoxin strongly depresses high-voltage activated currents, both in undifferentiated and in differentiated SH-SY5Y cells. Interestingly, the Ca agonist Bay K 8644 is effective, albeit with great variability from cell to cell, only in differentiated cells and only when barium is the current carrier through the Ca channels. A diversity of high-voltage activated Ca channels of distinct pharmacology has been recently observed in other kinds of neurons. This requires a redefinition of the role that voltage-dependent Ca channel subtypes can play in mammalian neurons.

Entities:  

Year:  1991        PMID: 12106483     DOI: 10.1111/j.1460-9568.1991.tb00838.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

Review 1.  Molecular and biophysical view of the Ca channel: a hypothesis regarding oligomeric structure, channel clustering, and macroscopic current.

Authors:  L J DeFelice
Journal:  J Membr Biol       Date:  1993-05       Impact factor: 1.843

2.  Age-dependent expression of high-voltage activated calcium currents during cerebellar granule cell development in situ.

Authors:  P Rossi; E D'Angelo; J Magistretti; M Toselli; V Taglietti
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

3.  Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model.

Authors:  Paola Luciani; Cristiana Deledda; Susanna Benvenuti; Ilaria Cellai; Roberta Squecco; Monica Monici; Francesca Cialdai; Giorgia Luciani; Giovanna Danza; Chiara Di Stefano; Fabio Francini; Alessandro Peri
Journal:  Cell Mol Life Sci       Date:  2010-05-23       Impact factor: 9.261

4.  Enhancement of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by phorbol esters with and without activation of protein kinase C.

Authors:  H L Reeve; P F Vaughan; C Peers
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

5.  Activation of phospholipase C in SH-SY5Y neuroblastoma cells by potassium-induced calcium entry.

Authors:  D Smart; A Wandless; D G Lambert
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

6.  Kinetic and pharmacological properties of high- and low-threshold calcium channels in primary cultures of rat hippocampal neurons.

Authors:  M Toselli; V Taglietti
Journal:  Pflugers Arch       Date:  1992-05       Impact factor: 3.657

7.  Block of human voltage-sensitive Na+ currents in differentiated SH-SY5Y cells by lifarizine.

Authors:  N A Brown; J A Kemp; G R Seabrook
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening.

Authors:  D Smart; G Smith; D G Lambert
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Mechanistic and functional changes in Ca2+ entry after retinoic acid-induced differentiation of neuroblastoma cells.

Authors:  Anna M Brown; Fiona C Riddoch; Andrew Robson; Christopher P F Redfern; Timothy R Cheek
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

10.  ω-Conotoxin GVIA mimetics that bind and inhibit neuronal Ca(v)2.2 ion channels.

Authors:  Charlotte Elisabet Tranberg; Aijun Yang; Irina Vetter; Jeffrey R McArthur; Jonathan B Baell; Richard J Lewis; Kellie L Tuck; Peter J Duggan
Journal:  Mar Drugs       Date:  2012-10-22       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.